Study of WS016 for treating high potassium levels
Part of Hormones & metabolism clinical trials.
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your potassium level is between 5.0 and 6.5 mmol/L (high but not extremely high).
- You have not had a severe drug allergy or allergic reaction to the study drug or its ingredients.
- You do not have certain heart conditions, such as a recent heart attack, severe arrhythmia, or heart failure with severe symptoms.
- You are not currently on dialysis.
- You have not taken other potassium-lowering drugs like sodium zirconium cyclosilicate within the last 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This study is looking at how common high potassium levels (hyperkalaemia) are and what factors increase the risk for people with certain health conditions. It may help doctors better understand and manage this condition.
This trial tests whether closely managing potassium levels during hemodialysis can help protect the heart in patients with kidney failure who are on maintenance dialysis. It aims to reduce the risk of heart problems related to potassium swings.
This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Hear when a new Hyperkalemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.